KalVista Pharmaceuticals (STU:4XC1) Dividend Payout Ratio : 0.00 (As of Jan. 2025)

View and export this data going back to 2016. Start your Free Trial

What is KalVista Pharmaceuticals Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. KalVista Pharmaceuticals's Dividend Payout Ratio for the months ended in Jan. 2025 was 0.00.

The historical rank and industry rank for KalVista Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

STU:4XC1's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.45
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2025-03-31), the Dividend Yield % of KalVista Pharmaceuticals is 0.00%.

KalVista Pharmaceuticals's Dividends per Share for the months ended in Jan. 2025 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

KalVista Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for KalVista Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KalVista Pharmaceuticals Dividend Payout Ratio Chart

KalVista Pharmaceuticals Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Dividend Payout Ratio

Get a 7-Day Free Trial

KalVista Pharmaceuticals Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of KalVista Pharmaceuticals's Dividend Payout Ratio

For the Biotechnology subindustry, KalVista Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

KalVista Pharmaceuticals's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, KalVista Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where KalVista Pharmaceuticals's Dividend Payout Ratio falls into.

Save Embed

;

Save Embed

;

KalVista Pharmaceuticals Dividend Payout Ratio Calculation

KalVista Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Apr. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Apr. 2024 )	/	EPS without NRI (A: Apr. 2024 )
	=	0	/	-3.243
	=	N/A

KalVista Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Jan. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2025 )	/	EPS without NRI (Q: Jan. 2025 )
	=	0	/	-0.878
	=	N/A

KalVista Pharmaceuticals (STU:4XC1) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

KalVista Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of KalVista Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

KalVista Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » KalVista Pharmaceuticals Inc (STU:4XC1) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

KALV:USA 4XC1:Germany

Address

55 Cambridge Parkway, Suite 901 East, Cambridge, MA, USA, 02142

Website

https://www.kalvista.com

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

KalVista Pharmaceuticals Headlines

No Headlines